Infliximab doing better vs Cyclophosphamide in severe #vascular #Behcet's. Data from FVSG #EULAR2024 #RheumTwitter #Vasculitis MJR EULAR

Shared inflammatory pathways of #RheumatoidArthritis& #atherosclerosis 👉🏼#Cardiovasculat risk in Rheumatic & Musculoskeletal Disease ➡️Major cause is #inflammation leading to accelerated artherosclerosis via Prof Michael Nurmohamed #EULAR2024

So much fun learning waltz at the EMEUNET networking event #EULAR2024 Thank you to the Visibility and Global affairs subcommittee for organising this! EULAR 1, 2, 3... 1, 2, 3...

Late breaking abstract session: Efficacity and safety of Nipocalimab in #Sjogrens, results of phase 2 Dahlias study #EULAR2024 CB

« Glucocorticoids are such old drugs and we still use them so much » says Josef Smolen Summary slide from « 75th anniversary of GCd, what have we learnt? » Dr. John Cush #EULAR2024

T2T strategy in RA during pregnancy improves time to procreate Results PreCARA (T2T median DAS28CRP 2.33) vs. PARA median DAS28CRP 3.84) median TTP 84d vs. 196d TTP exceeded 12 months in 23% of PreCARA pts compared to 42% in the PARA pts. Dr. John Cush #EULAR2024 POS0436

PMR patients get too much steroid. Data across 27 million people in England, n=39,438 with PMR. The blue are getting more pred than guidelines. Like everything in rheum: we need to be giving less pred, not more. Lumping PMR in with GCA won’t help. #EULAR2024 POS0411 Dr. John Cush

Nice summary of recent studies on #interleukin-6 receptor inhibitors IL-6Ri #tocilizumab #sarilumab for #PolyMyalgiaRheumatica #PMR via Prof Frank Buttgereit #EULAR2024

#EULAR2024 is over but I've brought a bit of Vienna's taste! Amazing congress: science but also #karaoke 🎤 and most of all, meeting dear friends and making new ones! Aurelie Najm PA Juge 🍸 Sophie Jojo Marc Scherlinger 🗞️ All EMEUNET, happy to join the community!

#PolyMyalgiaRheumatica & subclinical #GiantCellArteritis #GCA have 4x higher rate relapse than isolated #PMR 👉🏼Lower starting dose & rapid #glucocorticoid taper in 1st 3 months are risk factors for relapse via Prof Frank Buttgereit #EULAR2024

So, it has happened. A new journal is born in rheumatology with a bee 🐝 on its cover. Thank you, Stefano Bombardieri, for leading this niche journal, a spin-off of Clin Exp Rheumatol. Prevention is the next word in rheumatology ☂️ environmentalrheumatology.com

EMEUNET all together and CLs meetings! 🙌🏻 #CountryLiaison 🫶🏻

Our new subcommittee members are now available on our website!

Check the Level of Evidence and Support for bDMARDs by axSpA Subtype from the new ASAS-EULAR Recommendations for the Management of axSpA. See the updated slides of the management guidelines in the ASAS slide library: asas-group.org/education/asas…

📄 Hémorragie intra-alvéolaire chez des patients avec #vascularites associées aux #ANCA : résultats essai randomisé contrôlé #PEXIVAS 👤 Résumé par Drs Baptiste Chevet Kevin Chevalier Divi CORNEC & Bérengère MOLINA ➡️ drive.google.com/file/d/1KYOwG0… #maladiesrares #FAI2Ralupourvous #fsmr

A very nice day dedicated to organoids at the Faculté de pharmacie! Organoids from human 🤸🏻and animals 🐄 A lot of great talks 👍🏻 Cancéropôle GO labex_mabimprove

A really nice table on #autoantibodies in #Rheumatology By Mithu Maheswaranathan, MD Rheum OnePagers

🚀Join us for the next #EMEUNET Country Liaison Clinical Topics webinar "Inborn Errors of Immunity and Rheumatic Disorders" with Prof. Joanna Makowska, chaired by Dr. Aleksandra Opinc-Rosiak 🗓️ Wed, 24 July 2024 ⏰ 18:00 - 18:45 CEST 👉Register here: esor.eular.org/course/view.ph… EMEUNET

Introducing the #EMEUNET Peer Mentoring subcommittee! Chair: Alvise Berti Cathy Melong taleng Jelena Colic Jan Schirmer Shalaleh Karkon Morten Aagaard Nielsen Sarah Dyball Simone Battista Lisa Christ

Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study academic.oup.com/rheumatology/a…